A meta-analysis of the efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors as treatments for metastatic bladder cancer

BACKGROUND: This article is a meta-analysis aiming to systematically assess the efficacy and safety profiles of PD-1/PD-L1 inhibitors in patients with advanced or metastatic bladder cancer. METHODS: We extracted and examined data from phase I, II, and III clinical trials from the Medline, Embase, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Zhongyuan, Liang, Ye, Yang, Xuecheng, Li, Bin, Cui, Lili, Luo, Lei, Jia, Yuefeng, Wang, Yonghua, Niu, Haitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404681/
https://www.ncbi.nlm.nih.gov/pubmed/30881032
http://dx.doi.org/10.2147/OTT.S186271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404681/
https://www.ncbi.nlm.nih.gov/pubmed/30881032
http://dx.doi.org/10.2147/OTT.S186271

Ejemplares similares